|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 309/10 | (2006.01) |
| A61K 31/70 | (2006.01) | ||
| A61P 3/00 | (2006.01) |
| (11) | Number of the document | 2580225 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11791943.1 |
| Date of filing the European patent application | 2011-06-10 | |
| (97) | Date of publication of the European application | 2013-04-17 |
| (45) | Date of publication and mention of the grant of the patent | 2018-07-18 |
| (46) | Date of publication of the claims translation | 2018-08-10 |
| (86) | Number | PCT/CN2011/075554 |
| Date | 2011-06-10 |
| (87) | Number | WO 2011/153953 |
| Date | 2011-12-15 |
| (30) | Number | Date | Country code |
| PCT/CN2010/0738 | 2010-06-12 | WO |
| (72) |
CAI, Mengzhuang, CN
LIU, Qian, CN
XU, Ge, CN
LV, Binhua, CN
SEED, Brian, US
ROBERGE, Jacques Y., US
|
| (73) |
Theracos Sub, LLC,
225 Cedar Hill Street, Suite 200, Marlborough, MA 01752,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Benzilbenzeno SGLT2 inhibitoriaus kristalinė forma |
| CRYSTALLINE FORM OF BENZYLBENZENE SGLT2 INHIBITOR |
| Payment date | Validity (years) | Amount | |
| 2024-05-08 | 14 | 289.00 EUR |
| 2025-06-10 |